(AAPL) Apple has 6 more days to reach an agreement with Cisco over the iPhone trademark.
(ADM) Archer Daniels Midland priced $1.15B in notes and will repurchase more than $350M in common stock.
(AMR) AMR up 9% pre-market after Business Week noted it could be acquired for $46 to $52; Reuters reports that British Air and Goldman Sachs are not planning to bid.
(BPT) Prudhoe Bay noted as a SELL on Cramer’s MAD MONEY.
(BUCY) Bucyrus reports this morning.
(CAE) Cascade will replace ELK in the S&P Small Cap 600 Index.
(CBSS) COMPASS BANK UP 7% AFTER BEING ACQUIRED BY BBVA in Spain.
(CECO) Career Education trading down 12% after earnings yesterday.
(CPB) Campbell soup reports this morning.
(CMG) Chipotle traded up 4% after beating earnings.
(CPKI) California Pizza Kitchen $0.19 EPS vs $0.16e.
(DRTE) Dendrite posted a loss buyt reaffirmed 2007 targets.
(EL) Estee Lauder approved a 20M share buyback plan.
(FPIC)) FPIC INSURANCE reports this morning.
(FRO) Frontline noted as a SELL on Cramer’s MAD MONEY.
(FRNT) Frontier Airlines announced pilots agreed to new contract.
(GOOG) Google bought private Adscape for video game advertising for $23 million according to Red Herring.
(GT) Goodyear Tire reports this morning.
(HON) Honeywell announced a $3 Billion stock buyback plan, close to 8% of the stock.
(HRL) Hormel $0.57 EPS vs $0.58e.
(ICGE) INternet Capital reports this morning.
(ISV) Inspire wins 413M payment in pact with Insite Vision plus $19M milestone.
(KNDL) Kendle $0.18 EPS vs $0.17e.
(LMS) Lamson & Sessions reports this morning.
(LOOK) Looksmart traded down 1.5% after beating EPS targets, but missed revenues and guided revenues down.
(MSFT) Microsoft trading down 1.4% after Ballmer noted some analyst expectations were too high for Vista at analyst meeting.
(MYL) Mylan Labs announced final FDA approval for propranolol hydrochloride extended-release capsules.
(NABI ) Nabi Bio chairman resigned.
(SJM) JM Smucker $0.72 EPS vs $0.69e.
(SMDI) Sirenza Micro founder and wife are selling 7M shares of common stock.
(SPPI) Spectrum Pharmaceuticals announces completion of NDA filing for satraplatin for hormone refractory prostate cancer
(VC) Visteon reported -$0.31 EPS but had huge gains and huge charges; estimates were -$0.80; sees challenges continuing.
(WYE) Wyeth announced that a Federal Jury rules for Wyeth in hormone replacement trial.
Pre-Market Stock Notes (FEB 16, 2007)
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.